Williams Elizabeth Scp, Martins Thomas B, Shah Kevin S, Hill Harry R, Coiras Mayte, Spivak Adam M, Planelles Vicente
Department of Pathology, University of Utah School of Medicine, Salt Lake City, United States.
ARUP Institute for Clinical and Experimental Pathology, 1950 Circle of Hope Drive, Salt Lake City, United States.
J Clin Cell Immunol. 2022;13(6). Epub 2022 Nov 18.
Up to half of individuals who contract SARS-CoV-2 develop symptoms of long-COVID approximately three months after initial infection. These symptoms are highly variable, and the mechanisms inducing them are yet to be understood. We compared plasma cytokine levels from individuals with long-COVID to healthy individuals and found that those with long-COVID had 100% reductions in circulating levels of Interferon Gamma (IFNγ) and Interleukin-8 (IL-8). Additionally, we found significant reductions in levels of IL-6, IL-2, IL-17, IL-13, and IL-4 in individuals with long-COVID. We propose immune exhaustion as the driver of long-COVID, with the complete absence of IFNγ and IL-8preventing the lungs and other organs from healing after acute infection, and reducing the ability to fight off subsequent infections, both contributing to the myriad of symptoms suffered by those with long-COVID.
感染新冠病毒的个体中,高达一半的人在初次感染约三个月后会出现长期新冠症状。这些症状高度可变,引发症状的机制尚不清楚。我们比较了长期新冠患者与健康个体的血浆细胞因子水平,发现长期新冠患者的循环干扰素γ(IFNγ)和白细胞介素-8(IL-8)水平降低了100%。此外,我们发现长期新冠患者的IL-6、IL-2、IL-17、IL-13和IL-4水平也显著降低。我们提出免疫耗竭是长期新冠的驱动因素,IFNγ和IL-8的完全缺失使肺部和其他器官在急性感染后无法愈合,并降低了抵御后续感染的能力,这两者都导致了长期新冠患者出现的各种症状。